Analytical Data
-
Gene name
LETMD1
- Application
-
Alternative Names
HCCR1; HCRR-2; Cervical Cancer 1 Protooncogene; Cervical cancer proto-oncogene 2 protein
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q6P1Q0
-
Expression Region
Pro162~Asn347
-
Molecular Weight
25kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
LETMD1 (Lethal T-Cell Mediated Defense 1) is a relatively novel protein that has garnered interest in the field of cancer biology and immunology due to its potential role in regulating immune responses and cell survival. Initially identified in studies focusing on T-cell lineage differentiation and function, LETMD1 is believed to influence the immune system's ability to combat tumors and infections. Recent research has suggested that LETMD1 may be involved in the modulation of apoptosis and autophagy, critical processes for maintaining cellular homeostasis and responding to stress. Investigating the structural and functional characteristics of recombinant LETMD1 protein is essential for understanding its mechanistic roles in various cellular pathways. Furthermore, the production of LETMD1 as a recombinant protein allows for detailed biochemical characterization and the exploration of its interactions with other proteins. Such studies are vital for elucidating its potential as a therapeutic target or biomarker in cancer immunotherapy, offering a promising avenue for developing novel strategies to enhance immune responses against malignancies. Overall, the research on LETMD1 recombinant protein stands at the intersection of fundamental biology and potential clinical applications, aiming to uncover its significance in health and disease.
